Taipei

Taipei has emerged as a premier global hub for the life sciences ecosystem. The city is best known for its leadership in smart healthcare, where it leverages advanced information and communication technology (ICT) to pioneer AI-assisted diagnostics and digital health solutions.

At the heart of this progress is the Nangang Software Park and the National Biotechnology Research Park, which serve as critical clusters for biotechnology startups and multinational pharmaceutical firms.

Taipei’s robust medical device sector is a global leader in OEM/ODM manufacturing, specializing in high-precision instruments and connected medical devices that meet rigorous PIC/S GMP and FDA standards.

The region’s academic research is anchored by prestigious institutions like Taipei Medical University and Academia Sinica, which drive breakthroughs in translational medicine, regenerative medicine and precision oncology.

Furthermore, Taipei offers an unparalleled environment for clinical trials, supported by a comprehensive National Health Insurance (NHI) database that provides high-quality data for big data analytics and drug development.

With a burgeoning CDMO (contract development and manufacturing organization) sector, Taipei provides scalable infrastructure for the entire drug life cycle, from API production to commercialization.

As a gateway to the Asia-Pacific market, the city continues to attract international investment through strategic public-private partnerships and supportive regulatory frameworks.

Today, Taipei stands as a vital node in the global supply chain, offering a resilient and high-tech frontier for the future of biomedical engineering.